Rule 144 Notice: 70,000 Common Shares Planned Sale on 09/08/2025
Rhea-AI Filing Summary
Form 144 notice discloses a proposed sale of 70,000 shares of common stock through UBS Financial Services on 09/08/2025 with an aggregate market value of $6,402,200.00. The filing reports 51,312,748 shares outstanding for the class. The shares were acquired as founders' shares on 05/01/1991. The filer also reported a sale within the past three months of 40,000 common shares on 09/02/2025 for gross proceeds of $3,553,923.00. The form includes the standard seller representation that no material nonpublic information is known to the seller.
Positive
- Full regulatory disclosure of the proposed sale including broker, quantity, value, and sale date
- Previous sale reported (40,000 shares for $3,553,923), showing recent trading transparency
Negative
- None.
Insights
TL;DR: Routine Rule 144 notice disclosing an affiliate-originated sale; modest relative size versus total outstanding shares.
The filing documents a proposed brokered sale of 70,000 common shares with an indicated market value of $6.4 million. Relative to the reported 51.31 million shares outstanding, the proposed sale represents approximately 0.14% of the class, suggesting limited direct dilution or market impact solely from this transaction. The filing also notes a recent sale of 40,000 shares generating $3.55 million in proceeds. As a Rule 144 notice, the disclosure meets regulatory transparency requirements but does not provide operational or financial performance data about the issuer.
TL;DR: Routine insider/affiliate disposition under Rule 144; disclosure is compliance-focused rather than materially company-changing.
The document shows the seller holds founders' shares from 1991 and is using a broker to execute the sale, and it includes the customary attestation about absence of undisclosed material information. From a governance perspective, timely filing of Rule 144 notices preserves compliance and market transparency. The sizes disclosed (70,000 proposed; 40,000 previously sold) are small relative to total outstanding shares and therefore unlikely to trigger governance alarms or require additional corporate disclosures.
FAQ
What does the Form 144 for CRVL/issuer disclose?
How many shares of the class are outstanding according to the filing?
When were the shares being sold originally acquired?
Has the filer sold shares recently?
Who is the broker handling the proposed sale?